Regeneron Pharmaceuticals, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
18.38
Forward P/E Ratio
14.51
PEG Ratio
-4.90
17.09
Price-to-Sales (TTM)
5.62
2.50
304.65
Market Cap
80.38B
72.55B
Is it profitable?
Net Profit Margin (TTM)
31.41%
Gross Profit Margin
84.95%
Diluted EPS (TTM)
41.44
14.86%
14.34B
Is it growing?
2.50%
-8.00%
Is it risky?
0.40
9.51
4.13
2.97B
Who owns it?
90.84%
1.98%
2.45%
105.72M
98.55M
Does it pay?
0.49%
8.49%
Feb 20, 2026
Mar 5, 2026
How much cash?
8.61B
4.98B
3.26B
83.86
- Price
- 775.53
- Percent Change
- +15.26 (2.01%)
- Previous Close
- 760.27
- Open
- 767.70
- Low
- 755.44
- High
- 775.63
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$775.53
From 52W Low
+62.76%
From 52W High
-5.55%
Today
+2.01%
1Y Change
+34.47%
6M
$569.90
3M
$796.55
1M
$781.60
Today
$775.53
From 52W Low
+62.76%
From 52W High
-5.55%
Today
+2.01%
1Y Change
+34.47%
6M
$569.90
3M
$796.55
1M
$781.60
Today
$775.53
Expensive
within its 1-year price range
$775.53
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-0.8%
3M
-2.6%
6M
+36.1%
1Y
+34.5%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Regeneron Pharmaceuticals, Inc.
- Founded
- Jan 8, 1988
- Founders
- George Yancopoulos, Leonard S. Schleifer
- CEO
- Leonard S. Schleifer
- Employees
- 15,410
- Fiscal Year End
- Dec 31, 2025
- Address
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.regeneron.com
Indicators
Operating Cash Flow
4.98B
Net Income
4.50B
Backed by Cash
1.11
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
4.98B
Net Income
4.50B
Backed by Cash
1.11
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
18.38
Forward P/E Ratio
14.51
PEG Ratio
-4.90
17.09
Price-to-Sales (TTM)
5.62
2.50
304.65
Market Cap
80.38B
72.55B
Is it profitable?
Net Profit Margin (TTM)
31.41%
Gross Profit Margin
84.95%
Diluted EPS (TTM)
41.44
14.86%
14.34B
Is it growing?
2.50%
-8.00%
Is it risky?
0.40
9.51
4.13
2.97B
Who owns it?
90.84%
1.98%
2.45%
105.72M
98.55M
Does it pay?
0.49%
8.49%
Feb 20, 2026
Mar 5, 2026
How much cash?
8.61B
4.98B
3.26B
83.86
- Price
- 775.53
- Percent Change
- +15.26 (2.01%)
- Previous Close
- 760.27
- Open
- 767.70
- Low
- 755.44
- High
- 775.63
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$775.53
From 52W Low
+62.76%
From 52W High
-5.55%
Today
+2.01%
1Y Change
+34.47%
6M
$569.90
3M
$796.55
1M
$781.60
Today
$775.53
From 52W Low
+62.76%
From 52W High
-5.55%
Today
+2.01%
1Y Change
+34.47%
6M
$569.90
3M
$796.55
1M
$781.60
Today
$775.53
Expensive
within its 1-year price range
$775.53
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-0.8%
3M
-2.6%
6M
+36.1%
1Y
+34.5%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Regeneron Pharmaceuticals, Inc.
- Founded
- Jan 8, 1988
- Founders
- George Yancopoulos, Leonard S. Schleifer
- CEO
- Leonard S. Schleifer
- Employees
- 15,410
- Fiscal Year End
- Dec 31, 2025
- Address
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.regeneron.com